Panacea Biotec Limited (PANACEABIO.NS)

INR 544.6

(-1.37%)

Total Assets Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual total assets in 2023 was 12.4 Billion INR , down -2.4% from previous year.
Panacea Biotec Limited's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
Panacea Biotec Limited reported annual total assets of 12.71 Billion INR in 2022, down -28.69% from previous year.
Panacea Biotec Limited reported annual total assets of 17.82 Billion INR in 2021, up 51.21% from previous year.
Panacea Biotec Limited reported quarterly total assets of 12.72 Billion INR for 2023 Q2, down 0.0% from previous quarter.
Panacea Biotec Limited reported quarterly total assets of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Assets Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Total Assets of Panacea Biotec Limited (2023 - 2004)

Year	Total Assets	Total Assets Growth
2023	12.4 Billion INR	-2.4%
2022	12.71 Billion INR	-28.69%
2021	17.82 Billion INR	51.21%
2020	11.78 Billion INR	-15.21%
2019	13.9 Billion INR	1.07%
2018	13.75 Billion INR	-14.43%
2017	16.07 Billion INR	-13.67%
2016	18.62 Billion INR	0.41%
2015	18.54 Billion INR	-3.94%
2014	19.3 Billion INR	-0.66%
2013	19.43 Billion INR	5.65%
2012	18.39 Billion INR	-8.29%
2011	20.05 Billion INR	15.68%
2010	17.33 Billion INR	2.85%
2009	16.85 Billion INR	-1.5%
2008	17.11 Billion INR	31.67%
2007	12.99 Billion INR	25.9%
2006	10.32 Billion INR	2.17%
2005	10.1 Billion INR	114.51%
2004	4.71 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	- INR	-100.0%
2023 Q2	12.72 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 FY	12.4 Billion INR	-2.4%
2023 Q4	12.4 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2022 FY	12.71 Billion INR	-28.69%
2022 Q1	- INR	-100.0%
2022 Q2	13.5 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	12.71 Billion INR	0.0%
2021 Q4	17.82 Billion INR	0.0%
2021 Q2	12.47 Billion INR	0.0%
2021 FY	17.82 Billion INR	51.21%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2020 FY	11.78 Billion INR	-15.21%
2020 Q2	11.38 Billion INR	0.0%
2020 Q4	11.78 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2019 Q4	13.9 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2019 Q2	14.33 Billion INR	0.0%
2019 Q1	- INR	-100.0%
2019 FY	13.9 Billion INR	1.07%
2018 Q4	13.75 Billion INR	0.0%
2018 FY	13.75 Billion INR	-14.43%
2017 FY	16.07 Billion INR	-13.67%
2016 FY	18.62 Billion INR	0.41%
2015 FY	18.54 Billion INR	-3.94%
2014 FY	19.3 Billion INR	-0.66%
2013 FY	19.43 Billion INR	5.65%
2012 FY	18.39 Billion INR	-8.29%
2011 FY	20.05 Billion INR	15.68%
2010 FY	17.33 Billion INR	2.85%
2009 FY	16.85 Billion INR	-1.5%
2008 FY	17.11 Billion INR	31.67%
2007 FY	12.99 Billion INR	25.9%
2006 FY	10.32 Billion INR	2.17%
2005 FY	10.1 Billion INR	114.51%
2004 FY	4.71 Billion INR	0.0%

Peer Total Assets Comparison of Panacea Biotec Limited

Name	Total Assets	Total Assets Difference
Biocon Limited	560.7 Billion INR	97.787%
Blue Jet Healthcare Limited	10.58 Billion INR	-17.173%
Concord Biotech Limited	17 Billion INR	27.049%
Dishman Carbogen Amcis Limited	95.81 Billion INR	87.051%
Jubilant Ingrevia Limited	47.31 Billion INR	73.78%
Lyka Labs Limited	1.56 Billion INR	-691.632%
Piramal Pharma Limited	153.11 Billion INR	91.897%
SMS Lifesciences India Limited	3.9 Billion INR	-217.7%
Supriya Lifescience Limited	9.21 Billion INR	-34.675%
Syngene International Limited	61.51 Billion INR	79.832%
TAKE Solutions Limited	881.05 Million INR	-1308.183%
Zota Health Care Limited	2.28 Billion INR	-443.375%